14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for ABBV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 166.57 1.35 %
R2 165.52 0.712 %
R1 164.87 0.317 %
Current price: 164.35
Support S1 162.77 -0.96 %
S2 162.12 -1.36 %
S3 161.07 -2.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 181.20 10.25 %
R2 176.27 7.25 %
R1 167.90 2.16 %
Current price 164.35
Support S1 163.79 -0.341%
S2 161.52 -1.72%
S3 159.62 -2.88%

ABBV Predictions History

4 years ago
w142712 predicted that ABBV for 2020-03-23 is going

Rank:

4 years ago
Kalpa Fernando predicted that ABBV for 2020-02-18 is going

Rank:

4 years ago
JS predicted that ABBV for 2020-02-18 is going $92.49 (-1.66%)

4 years ago
Chaser predicted that ABBV for 2019-12-26 is going $91.13 (1.42%)

4 years ago
Alan predicted that ABBV for 2019-11-26 is going $88.63 (1.04%)

4 years ago
Stefan.Biclineru.116932 predicted that ABBV for 2019-10-07 is going $74.66 (0.00%)

Rank:

4 years ago
Jorge predicted that ABBV for 2019-07-10 is going $85.51 (20.03%)

Rank:

4 years ago
Chaser predicted that ABBV for 2019-06-28 is going $68.10 (-6.35%)

4 years ago
Monika.Vaitkien.C4.97.93677 predicted that ABBV for 2019-06-26 is going $63.53 (-6.57%)

Rank:

4 years ago
JS predicted that ABBV for 2019-06-26 is going $67.91 (-0.13%)

Click to get the best stock tips daily for free!

About AbbVie Inc

AbbVie AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ... ABBV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT